EMPOWER: Empowering the Management of Pain-Obesity-Weight Through Enhanced Reward
Empowering the Management of Pain-Obesity-Weight Through Enhanced Reward
2 other identifiers
interventional
37
1 country
1
Brief Summary
The central objective of research is to examine the feasibility and acceptability of an 8-month single-arm behavioral intervention (i.e., EMPOWER) among overweight/obese middle-aged and older adults with moderate-to-high impact low back pain. Intervention content will focus on standard behavioral weight loss treatment and cognitive-behavioral pain coping therapy with a focus on environmental reward and positive affect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable low-back-pain
Started Nov 2021
Typical duration for not_applicable low-back-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2021
CompletedFirst Posted
Study publicly available on registry
April 20, 2021
CompletedStudy Start
First participant enrolled
November 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2024
CompletedResults Posted
Study results publicly available
June 6, 2025
CompletedJune 6, 2025
April 1, 2025
2.2 years
April 1, 2021
January 17, 2025
May 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Session-level Engagement (NOTE: This is a Pilot Study and There is Not a True Primary Outcome. There Are Several Descriptive Outcomes That Will Inform Our Decision to Proceed to a Traditional, Fully Powered Clinical Trial).
Treatment Engagement Questionnaire: 6-item study-adapted questionnaire assessing perceptions of engagement, interest in the session content, and usefulness of the home activities. Items are rated on a 0 to 8 scale with the mean value across sessions calculated. The total scale is create by taking the mean of the items, and has a possible range of 0 (minimum) to 8 (maximum) score. There are no subscales. Higher scores indicate greater treatment engagement.
Assessed at each session (every other week) up to 8 months
Global Treatment Engagement
Number of participants who completed the intervention (defined as attending the final group session)
Baseline to 4 months
Participant Satisfaction
A single treatment satisfaction item ("In an overall, general sense, how satisfied are you with the intervention program you received?"). This item was rated on a 1 to 4 scale, with a higher score indicating greater satisfaction with the treatment.
Month 4
Participant Satisfaction
A single treatment satisfaction item ("In an overall, general sense, how satisfied are you with the intervention program you received?"). This item was rated on a 1 to 4 scale, with a higher score indicating greater satisfaction with the treatment.
Month 8
Treatment Credibility
Treatment Expectation Questionnaire: 7-item study-developed questionnaire assessing the credibility and reasonableness of the intervention. Items are rated on a 0 to 10 scale. A mean score was calculated for the questionnaire. Higher scores were indicative of greater treatment credibility.
Baseline
Enrollment Rate
Percentage of participants who enroll that commence treatment.
Baseline to Week 1
Enrollment Rate
Number of participants enrolled per week during active recruitment.
63 Weeks
Participant Retention
Percentage of enrolled participants who complete the 8-month time-point.
Baseline to 8 Months
Secondary Outcomes (5)
Body Weight Change
4 months
Pain Impact Change
4 months
Pleasant Activity Engagement
Baseline to 8 Months
Meaningful Activity Participation Change
4 months
Global Treatment Engagement
Baseline to 8 months
Study Arms (1)
In-Person (or Remote) Intervention Visits
EXPERIMENTALParticipants will initially complete a baseline assessment assessing study eligibility. The intervention includes 8 core in-person group sessions and 8 optional in-person group sessions (1.5 hours each) targeting standard weight loss and pain treatment content and eight individual phone calls (30 minutes each) focusing primarily on increasing environmental reward and positive affect. Intervention sessions may be delivered online through protected health information (PHI) Zoom. Group sessions will be delivered every-other week and phone calls will occur every-other week (during weeks with no group). Sessions will be administered by a study interventionist with bachelors- or masters-level training and certification in health education or a related field (e.g., Certified Health Education Specialist), and materials will be developed to be appropriate for delivery by this level of training, given the potential for greater availability of these types of health professionals.
Interventions
Participants will be asked to engage in self-administered activities during the intervention including pleasant activity scheduling, values clarification, mindfulness practice, goal setting, standard pain coping skills, and weight management including nutrition education and physical activity monitoring.
Eligibility Criteria
You may qualify if:
- years of age
- Have a BMI≥25kg/m2
- Endorse pain in the lower back region (i.e., space between the lower posterior margin of the rib cage and the horizontal gluteal fold), knees, or hips
- Pain must occur on at least 50% of the days in the previous six months
- Pain must be rated, at minimum, of moderate intensity (rating of 3 on a numeric rating scale ranging from 0-10)
- Pain impact must be rated as moderate to severe
- Study physician reviews medical record and declares patient medically appropriate for exercise protocol
You may not qualify if:
- Current participation in another psychological treatment or structured weight loss program
- Severe psychiatric illness not adequately controlled by medication or other conditions anticipated to impair intervention engagement (e.g., substance abuse/dependence)
- Presence of chronic, malignant pain (e.g., cancer)
- Significant cognitive impairment (\<26) on the Montreal Cognitive Assessment (MoCA)
- Inability to read and write English
- Currently undergoing radiation or chemotherapy for cancer
- Self-reported cardiac event in the past 6 months or self-reported Heart Failure (CHF)
- Currently pregnant or breastfeeding, or planning to become pregnant during the study time period
- Back, knee, or hip surgery within the past six months of study entry (or planned surgical interventions for pain during forecasted study participation)
- If currently taking prescription analgesic or psychotropic medication, must be stabilized on these treatments for \>4 weeks prior to the baseline assessment
- Blood pressure higher than 180/100 mm Hg at baseline assessment
- Has had bariatric surgery in the past year or is planning to have it in the next year
- If participant reports the presence of systemic inflammatory disease (e.g., rheumatoid arthritis), the study physician will be consulted to determine eligibility
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Floridalead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
University of Florida
Gainesville, Florida, 32610, United States
Related Publications (1)
McVay MA, Scotti K, Cheong J, McGargill S, Anton SA, Bartley EJ. Addressing co-occurring chronic pain and obesity simultaneously in a behavioral intervention: a pilot trial. Pilot Feasibility Stud. 2026 Jan 31. doi: 10.1186/s40814-026-01764-3. Online ahead of print.
PMID: 41620768DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Emily Bartley
- Organization
- University of Florida
Study Officials
- PRINCIPAL INVESTIGATOR
Emily J Bartley, Ph.D
University of Florida
- PRINCIPAL INVESTIGATOR
Megan A McVay, Ph.D
University of Florida
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 1, 2021
First Posted
April 20, 2021
Study Start
November 12, 2021
Primary Completion
January 31, 2024
Study Completion
January 31, 2024
Last Updated
June 6, 2025
Results First Posted
June 6, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share